Involvement of angiotensin II in intestinal cholesterol absorption

被引:7
|
作者
Nakamura, Kazuo [2 ]
Matsui, Takanori [1 ]
Adachi, Hisashi [3 ]
Yamagishi, Sho-Ichi [1 ]
机构
[1] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan
[2] Nakamura Clin, Kitakyushu, Fukuoka, Japan
[3] Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka 830, Japan
关键词
Cholesterol absorption; NPC1L1; Angiotensin II; Oxidative stress; DIABETIC VASCULAR COMPLICATIONS; CORONARY-ARTERY-DISEASE; CELL-LINE CACO-2; PLANT STEROLS; POSTPRANDIAL LIPOPROTEINS; THERAPEUTIC STRATEGY; LIPID ABSORPTION; PLASMA-LEVELS; FACTOR PEDF; TRANSPORTERS;
D O I
10.1016/j.phrs.2009.12.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Niemann-Pick C1-like 1 (NPC1L1) protein is identified as a key molecule of cholesterol absorption into the intestine. Although there is a controversy about the association between sitosterol levels and cardiovascular disease (CVD), cholesterol absorption may contribute to the increased risk for CVD because increased levels of sitosterol, a marker of cholesterol absorption, are associated with future cardiovascular events in high-risk patients. However, which anthropometric and metabolic variables could regulate serum levels of sitosterol in humans and whether serum sitosterol levels might reflect transport function of NPC1L1 are largely unknown. In this study, we first investigated the independent determinants of serum sitosterol levels in apparently healthy patients not taking lipid-lowering agents. We next examined the effects of angiotensin II on NPC1L1 gene and protein expression in differentiated Caco-2 cells. Seventy apparently health patients not taking lipid-lowering agents (28 men and 42 women, mean age 73.7 +/- 10.1 years old) underwent a complete history and physical examination, determination of blood chemistries, including serum levels of sitosterol. Univariate regression analysis showed that serum levels of sitosterol were associated with low-density-lipoprotein (LDL)-cholesterol (r = 0.284, p = 0.021) and use of the renin-angiotensin system (RAS) inhibitors (r = -0.289, p = 0.018). By the use of multiple stepwise regression analyses, use of RAS inhibitors (p = 0.025) was remained significant independently. Further, angiotensin II was found to up-regulate NPC1L1 mRNA and protein levels in Caco-2 cells, which were completely blocked by an angiotensin II type 1 receptor blocker or an anti-oxidant, N-acetylcysteine. The present study suggests the possible involvement of RAS in NPC1L1 expression in vitro and cholesterol absorption in humans. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:460 / 465
页数:6
相关论文
共 50 条
  • [1] Inhibition of intestinal cholesterol absorption by ezetimibe in humans
    Sudhop, T
    Lütjohann, D
    Kodal, A
    Igel, M
    Tribble, DL
    Shah, S
    Perevozskaya, I
    von Bergmann, K
    CIRCULATION, 2002, 106 (15) : 1943 - 1948
  • [2] Cholesterol esterase accelerates intestinal cholesterol absorption
    Ikeda, I
    Matsuoka, R
    Hamada, T
    Mitsui, K
    Imabayashi, S
    Uchino, A
    Sato, M
    Kuwano, E
    Itamura, T
    Yamada, K
    Tanaka, K
    Imaizumi, K
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2002, 1571 (01): : 34 - 44
  • [3] Associations between SNPs in Intestinal Cholesterol Absorption and Endogenous Cholesterol Synthesis Genes with Cholesterol Metabolism
    Schroor, Maite M.
    Mokhtar, Fatma B. A.
    Plat, Jogchum
    Mensink, Ronald P.
    BIOMEDICINES, 2021, 9 (10)
  • [4] Intestinal Cholesterol Absorption and Cardiovascular Risk
    Weingaertner, Oliver
    Bjoerkhem, Ingemar
    Luetjohann, Dieter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (07) : 695 - 696
  • [5] Dietary Phospholipids and Intestinal Cholesterol Absorption
    Cohn, Jeffrey S.
    Kamili, Alvin
    Wat, Elaine
    Chung, Rosanna W. S.
    Tandy, Sally
    NUTRIENTS, 2010, 2 (02): : 116 - 127
  • [6] Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans
    Davidson, Michael H.
    Voogt, Jason
    Luchoomun, Jayraz
    Decaris, Julie
    Killion, Salena
    Boban, Drina
    Glass, Alexander
    Mohammad, Hussein
    Lu, Yun
    Villegas, Deona
    Neese, Richard
    Hellerstein, Marc
    Neff, David
    Musliner, Thomas
    Tomassini, Joanne E.
    Turner, Scott
    ATHEROSCLEROSIS, 2013, 230 (02) : 322 - 329
  • [7] Involvement of Angiotensin II and Reactive Oxygen Species in Pancreatic Fibrosis
    Sakurai, Toshiharu
    Kudo, Masatoshi
    Fukuta, Nobuhiro
    Nakatani, Tatsuya
    Kimura, Masatomo
    Park, Ah-Mee
    Munakata, Hiroshi
    PANCREATOLOGY, 2011, 11 : 7 - 13
  • [8] Brain Angiotensin II Involvement in Chronic Mental Disorders
    Martin Basmadjian, Osvaldo
    Belen Occhieppo, Victoria
    Andrea Marchese, Natalia
    Baiardi, Gustavo
    Bregonzio, Claudia
    PROTEIN AND PEPTIDE LETTERS, 2017, 24 (09) : 817 - 826
  • [9] Involvement of neutral sphingomyelinase in the angiotensin II signaling pathway
    Bautista-Perez, Rocio
    del Valle-Mondragon, Leonardo
    Cano-Martinez, Agustina
    Perez-Mendez, Oscar
    Escalante, Bruno
    Franco, Martha
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2015, 308 (10) : F1178 - F1187
  • [10] Inhibition of intestinal cholesterol absorption might explain cholesterol-lowering effect of telmisartan
    Inoue, T.
    Taguchi, I.
    Abe, S.
    Toyoda, S.
    Sakuma, M.
    Node, K.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (01) : 103 - 110